How much universal should be the access to treatment to HIV/Aids?
According to Luis Soto Ramirez, co-chair of AIDS 2008, in his talk with the journalists in the National Press Foundation training for journalists, hold on 29 July-1 August, this issue should be carefully considered:
“If we fix the price too low for the drugs given for treating HIV/Aids, the pharmaceutical companies will have no interest in funding the development of new drugs”, he said.
Indeed a controversial issue, in a context in which several people and organisations from developing countries have been strongly supporting the universal access to treatment on HIV/Aids.
A (hot) debate is planned to be held during AIDS 2008.
Luisa Massarani, SciDev.Net/Latin America and the Caribbean